1951:TSEJinxin Fertility Group Limited Analysis
Data as of 2026-08-31 - not real-time
HK$2.22
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
The moving-average structure behind Jinxin Fertility Group Limited is neutral at HKD 2.22, with no clear ordering between short and long averages. With RSI at 52.5 the momentum picture is neutral, alongside a bullish MACD signal. Watch HKD 2.06 as support and HKD 2.42 as the nearer resistance level.
On valuation the read is undervalued — earnings multiple of 27.8 versus a 30.4 sector average, in line with the peer group. Analyst price targets sit 42.7% above the current price. Revenue is growing at 6.6% on a 6.3% profit margin. The 1.84% dividend yield looks covered by current payout levels.
Risk scores 6 out of 10, which is elevated for this asset class. With 30-day volatility of 32.2%, a beta of 0.30 and a maximum drawdown of 33.7%, position sizing matters here. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
The horizons diverge: hold near-term but buy on a long view, at 5/10 conviction over the longer horizon.
On valuation the read is undervalued — earnings multiple of 27.8 versus a 30.4 sector average, in line with the peer group. Analyst price targets sit 42.7% above the current price. Revenue is growing at 6.6% on a 6.3% profit margin. The 1.84% dividend yield looks covered by current payout levels.
Risk scores 6 out of 10, which is elevated for this asset class. With 30-day volatility of 32.2%, a beta of 0.30 and a maximum drawdown of 33.7%, position sizing matters here. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
The horizons diverge: hold near-term but buy on a long view, at 5/10 conviction over the longer horizon.
Top Market Events
Microsoft and our third-party vendors use cookies to store and access information such as unique IDs and personal...Hosted on MSN7monJinxin Fertility narrows IVF volume decline and signals recovery momentum in 2025Jinxin Fertility...Hosted on MSN9monJinxin Fertility Group Announces EGM and 2025 Share Scheme DetailsClaim 60% off TipRanks Premium for...
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 4/10
Key Factors
- Trading below the 200-day average of 2.34
- MACD momentum is positive
- Maximum drawdown of 33.7%
Medium Term
1–3 yearsPositive
Model confidence: 4/10
Key Factors
- P/E of 27.8 versus sector average of 30.4
- Trading below the 200-day average of 2.34
- Analyst targets imply +42.7% versus the current price
Long Term
> 3 yearsPositive
Model confidence: 5/10
Key Factors
- P/E of 27.8 versus sector average of 30.4
- Analyst targets imply +42.7% versus the current price
- Dividend yield of 1.84%
Key Metrics & Analysis
Financial Health
Revenue Growth6.60%
Profit Margin6.26%
P/E Ratio27.8
ROE1.87%
ROA1.84%
Debt/Equity33.51
P/B Ratio0.6
Industry P/E30.4
Technical Analysis
TrendNeutral
RSI52.5
SupportHK$2.06
ResistanceHK$2.42
MA 20HK$2.18
MA 50HK$2.15
MA 200HK$2.34
MACDBullish
VolumeIncreasing
Fear & Greed Index94.38
Valuation
Target PriceHK$3.17
Upside/Downside42.68%
GradeUndervalued
TypeBlend
Dividend Yield1.84%
Risk Assessment
Beta0.30
Volatility32.22%
Sector RiskMedium
Reg. RiskHigh
Geo RiskHigh
Currency RiskHigh
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.